1st Report on Implementation of the American Pandemic Preparedness Plan Cover

At the time of publication of this report, coronavirus disease of 2019 (COVID-19) has taken the lives of over 1 million Americans—and more than 6.4 million around the world—with many recovered patients living with long-term effects. As staggering as the losses of the last nearly 3 years have been, COVID-19 was a moderate pandemic, and as a result...

NIIMBL Report 2021 - 2022 Cover
Biomanufacturing, Biopharmaceutical

This Annual Report covers NIIMBL’s accomplishments from March 1, 2021 to February 28, 2022.

The NIIMBL mission is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing...

Adv TRL for MFG USA Institute projects

The Departments of Commerce, Defense (DOD), and Energy (DOE) have established a network of innovation institutes—known as Manufacturing USA institutes—to promote research, development, and commercialization of advanced manufacturing technologies. Manufacturing USA institutes reported making progress toward achieving their technology goals. Progress...

MFG USA Highlights report cover

This past year brought the country and our world unprecedented challenges, which now present opportunities to innovate and build a new path forward. Using lessons from this year, the manufacturing industry is poised to undergo a transformation.

Supporting this work are the institutes that are part of Manufacturing USA®, a national network of public...

NIIMBL Annual Report 2020-21 Cover
Biopharmaceutical, COVID-19, Workforce

NIIMBL, the Manufacturing USA institute for biopharmaceutical manufacturing innovation, has released its 2020–2021 Annual Report covering the period from March 2020 through February 2021. Amid the global COVID-19 pandemic, NIIMBL swiftly backed innovative projects that supported the U.S. response to the COVID-19 pandemic. Its community came...

Manufacturing USA Institute Evaluation Renewal Process and Performance Standards
Biopharmaceutical, Manufacturing

The National Institute of Standards and Technology (NIST) Office of Advanced Manufacturing (OAM) has published a report outlining the evaluation and renewal process for NIST-sponsored Manufacturing USA institutes. The report describes the performance standards developed by NIST following Manufacturing USA’s 2019 reauthorization, which allows NIST...

MFG USA Highlights Report Cover
Highlighting Manufacturing Innovation, Collaboration, and Education

This comprehensive report highlights the manufacturing technology and workforce development innovations underway at the manufacturing innovation institutes that are part of Manufacturing USA®. Institutes work with members from the manufacturing industry, academia, government...

Advancing America's Global Leadership in Science and Technology

The White House Office of Science and Technology Policy (OSTP) today released “Advancing America’s Global Leadership in Science and Technology, Trump Administration Highlights: 2017-2020.” The document is a selection of significant investments, accomplishments, policies, and other actions undertaken by President Trump to advance science and...

NIIMBL Annual Report 2019 - 2020
Biopharmaceutical, COVID-19

We are pleased to share NIIMBL’s 2019-2020 Annual Report covering the period from March 2019 through February 2020. It celebrates their collective accomplishments, which reflect the commitment and engagement of diverse individuals and organizations across the biopharmaceutical manufacturing ecosystem.

As they share and reflect on NIIMBL’s many...

Biopharmaceutical, Cybersecurity

Cyberbiosecurity is an emerging discipline that addresses the unique vulnerabilities and threats that occur at the intersection of cyberspace and biotechnology. Advances in technology and manufacturing are increasing the relevance of cyberbiosecurity to the biopharmaceutical manufacturing community in the United States. Threats may be associated...

Thumbnail
Biomanufacturing, Biopharmaceutical, Education, Workforce

The biopharmaceutical industry makes a substantial impact on the health, well-being, and economic prosperity of the nation. The industry develops and manufactures life-changing therapies for patients and contributes significantly to the U.S. economy. Currently, the industry accounts for nearly $800B of total economic activity per year and directly...